DMD Highlight: Methadone is an Inactivating Substrate for Aromatase
Posted on 1/1/0001 12:00:00 AM
|
Tags:
Aromatase is a steroid-metabolizing enzyme, once thought to only catalyze the conversion of androgens to estradiol and estrone. However, results reported by Lu et al in the August, 2010, issue of Drug Metabolism and Disposition demonstrate that aromatase may also play a role in metabolizing methadone. In addition, the metabolism of methadone by aromatase results in destruction of the enzyme’s activity. It follows that the use of methadone may cause changes in endogenous steroid metabolism, as well as resulting in unanticipated drug-drug interactions. This work is the first known connection between methadone and steroid metabolism, suggesting the possibility that that inhibition of aromatase may contribute to the “endocrine” side effects experienced by patients taking methadone. See article at Drug Metab. Dispos. 2010, 38:1308-1313